ADMA vs. BMY
Compare and contrast key facts about ADMA Biologics, Inc. (ADMA) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ADMA or BMY.
Correlation
The correlation between ADMA and BMY is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ADMA vs. BMY - Performance Comparison
Key characteristics
ADMA:
3.56
BMY:
0.23
ADMA:
4.20
BMY:
0.57
ADMA:
1.56
BMY:
1.07
ADMA:
4.76
BMY:
0.15
ADMA:
16.40
BMY:
0.83
ADMA:
15.00%
BMY:
8.47%
ADMA:
69.05%
BMY:
30.86%
ADMA:
-91.28%
BMY:
-70.62%
ADMA:
-5.79%
BMY:
-32.53%
Fundamentals
ADMA:
$5.08B
BMY:
$100.17B
ADMA:
$0.81
BMY:
-$4.41
ADMA:
0.00
BMY:
1.12
ADMA:
11.92
BMY:
2.07
ADMA:
14.57
BMY:
6.13
ADMA:
$344.58M
BMY:
$36.44B
ADMA:
$180.30M
BMY:
$23.27B
ADMA:
$123.41M
BMY:
$11.69B
Returns By Period
In the year-to-date period, ADMA achieves a 24.26% return, which is significantly higher than BMY's -11.05% return. Over the past 10 years, ADMA has outperformed BMY with an annualized return of 9.01%, while BMY has yielded a comparatively lower 0.16% annualized return.
ADMA
24.26%
3.40%
35.04%
243.71%
51.42%
9.01%
BMY
-11.05%
-17.17%
-5.46%
6.94%
-0.50%
0.16%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ADMA vs. BMY — Risk-Adjusted Performance Rank
ADMA
BMY
ADMA vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ADMA vs. BMY - Dividend Comparison
ADMA has not paid dividends to shareholders, while BMY's dividend yield for the trailing twelve months is around 4.96%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADMA ADMA Biologics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BMY Bristol-Myers Squibb Company | 4.96% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% |
Drawdowns
ADMA vs. BMY - Drawdown Comparison
The maximum ADMA drawdown since its inception was -91.28%, which is greater than BMY's maximum drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for ADMA and BMY. For additional features, visit the drawdowns tool.
Volatility
ADMA vs. BMY - Volatility Comparison
ADMA Biologics, Inc. (ADMA) has a higher volatility of 19.50% compared to Bristol-Myers Squibb Company (BMY) at 9.93%. This indicates that ADMA's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ADMA vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between ADMA Biologics, Inc. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities